Targeting SDF-1/CXCR4 to Inhibit Tumour Vasculature for Treatment of Glioblastomas

Overview

Journal Br J Cancer

Specialty Oncology

Date 2011 May 19

PMID 21587260

Citations 53

Authors

D Tseng

D A Vasquez-Medrano

J M Brown

Affiliations

Soon will be listed here.

Abstract

Local recurrence of glioblastomas is a major cause of patient mortality after definitive treatment. This review discusses the roles of the chemokine stromal cell-derived factor-1 and its receptor CXC chemokine receptor 4 (CXCR4) in affecting the sensitivity of glioblastomas to irradiation. Blocking these molecules prevents or delays tumour recurrence after irradiation by inhibiting the recruitment of CD11b+ monocytes/macrophages that participate in revascularising the tumour. We review the literature pertaining to the mechanism by which revascularisation occurs following tumour irradiation using experimental models. Areas of interest and debate in the literature include the process by which endothelial cells die after irradiation and the identity/origin of the cells that reconstitute the tumour blood vessels after injury. Understanding the processes that mediate tumour revascularisation will guide the improvement of clinical strategies for preventing recurrence of glioblastoma after irradiation.

Citing Articles

PIEZO1 Promotes the Migration of Endothelial Cells via Enhancing CXCR4 Expression under Simulated Microgravity.

Wang Y, Li C, Wang R, Zhao X, Pan Y, Zhang Q Int J Mol Sci. 2024; 25(13).

PMID: 39000362 PMC: 11242226. DOI: 10.3390/ijms25137254.

Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy.

Blanchard R, Adjei I RSC Adv. 2023; 13(45):31411-31425.

PMID: 37901257 PMC: 10603567. DOI: 10.1039/d3ra01153d.

New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets.

Lin Y, Hou Y, Wang H, Shan Y Theranostics. 2023; 13(12):3925-3942.

PMID: 37554282 PMC: 10405844. DOI: 10.7150/thno.82911.

Caspase-3 in glioma indicates an unfavorable prognosis by involving surrounding angiogenesis and tumor cell repopulation.

Feng X, Zhu F, Dai L, Liu X, Shao L, Hao L J Neurooncol. 2023; 163(2):313-325.

PMID: 37195411 DOI: 10.1007/s11060-023-04339-x.

Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation.

Fougner V, Hasselbalch B, Lassen U, Weischenfeldt J, Poulsen H, Urup T Neurooncol Adv. 2022; 4(1):vdac157.

PMID: 36325372 PMC: 9616055. DOI: 10.1093/noajnl/vdac157.

References

Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. DOI: 10.1038/nm1075. View

Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T . Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science. 1993; 261(5121):600-3. DOI: 10.1126/science.8342023. View

Ahn G, Tseng D, Liao C, Dorie M, Czechowicz A, Brown J . Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci U S A. 2010; 107(18):8363-8. PMC: 2889597. DOI: 10.1073/pnas.0911378107. View

McDonald M, Shu H, Curran Jr W, Crocker I . Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. Int J Radiat Oncol Biol Phys. 2010; 79(1):130-6. DOI: 10.1016/j.ijrobp.2009.10.048. View

Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y . The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature. 1998; 393(6685):591-4. DOI: 10.1038/31261. View

Imaizumi N, Monnier Y, Hegi M, Mirimanoff R, Ruegg C . Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting. PLoS One. 2010; 5(6):e11084. PMC: 2884035. DOI: 10.1371/journal.pone.0011084. View

Tanabe S, Heesen M, Yoshizawa I, Berman M, Luo Y, Bleul C . Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol. 1997; 159(2):905-11. View

Kioi M, Vogel H, Schultz G, Hoffman R, Harsh G, Brown J . Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest. 2010; 120(3):694-705. PMC: 2827954. DOI: 10.1172/JCI40283. View

Tilton B, Ho L, Oberlin E, Loetscher P, Baleux F, Clark-Lewis I . Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med. 2000; 192(3):313-24. PMC: 2193218. DOI: 10.1084/jem.192.3.313. View

10.

Aicher A, Rentsch M, Sasaki K, Ellwart J, Fandrich F, Siebert R . Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res. 2007; 100(4):581-9. DOI: 10.1161/01.RES.0000259562.63718.35. View

11.

Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S . Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci U S A. 2008; 105(18):6620-5. PMC: 2365563. DOI: 10.1073/pnas.0710516105. View

12.

de Palma M, Venneri M, Galli R, Sergi Sergi L, Politi L, Sampaolesi M . Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell. 2005; 8(3):211-26. DOI: 10.1016/j.ccr.2005.08.002. View

13.

Burns J, Summers B, Wang Y, Melikian A, Berahovich R, Miao Z . A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006; 203(9):2201-13. PMC: 2118398. DOI: 10.1084/jem.20052144. View

14.

Ahn G, Brown J . Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell. 2008; 13(3):193-205. PMC: 2967441. DOI: 10.1016/j.ccr.2007.11.032. View

15.

Ganju R, Brubaker S, Meyer J, Dutt P, Yang Y, Qin S . The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem. 1998; 273(36):23169-75. DOI: 10.1074/jbc.273.36.23169. View

16.

Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R . Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121(3):335-48. DOI: 10.1016/j.cell.2005.02.034. View

17.

Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A . Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003; 300(5622):1155-9. DOI: 10.1126/science.1082504. View

18.

Budach W, Taghian A, Freeman J, Gioioso D, Suit H . Impact of stromal sensitivity on radiation response of tumors. J Natl Cancer Inst. 1993; 85(12):988-93. DOI: 10.1093/jnci/85.12.988. View

19.

Udagawa T, Birsner A, Wood M, DAmato R . Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution. Cancer Res. 2007; 67(5):2040-5. DOI: 10.1158/0008-5472.CAN-06-2877. View

20.

Jin D, Shido K, Kopp H, Petit I, Shmelkov S, Young L . Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med. 2006; 12(5):557-67. PMC: 2754288. DOI: 10.1038/nm1400. View